Synlogic
@synlogic_tx
Followers
3K
Following
660
Media
831
Statuses
1K
Synlogic is a clinical-stage biotech company advancing novel, oral, non-systemically absorbed biotherapeutics to transform the care of serious diseases.
Cambridge, MA
Joined September 2014
Last week, we announced the end of our PKU study, Synpheny-3, and that Synlogic will cease operations. Our sincere thanks to all who worked with us, and especially to the PKU & HCU communities, who inspired us and enabled our pursuit of new medicines.
0
2
20
The #PKU Synpheny-3 Clinical Trial is now available in Nashville, TN! Virtual, hybrid, and in-person options for participation are available. Scan the QR code or visit to learn more.
1
0
0
The #PKU Synpheny-3 Clinical Trial is now available in Chicago, IL! Virtual, hybrid, and in-person options for participation are available. Scan the QR code to learn more!
0
0
1
Congrats authors! Proud of this manuscript on the journey of SYNB1353, our drug candidate for classical #HCU, published in Cell Host & Microbe: :@CellPressNews #inbornerrors #homocystinuria #rarediseases #synbio #syntheticbiology
0
1
3
Last year, SYNB1934 received the FDA's Rare Pediatric Disease, Fast Track, and Orphan Drug designations, Orphan designation from the EMA, AND the WHO's go-ahead for the non-proprietary name: labafenogene marselecobac! Learn more:
0
0
1
Learn about Synlogic's focus on rare metabolic diseases, and our lead asset, SYNB934, now in Phase 3 with a milestone-rich year ahead, in this recent webcast: Thank you @SidotiResearch! #sidoti $SYBX #SYBX #biotechstocks $XBI
0
0
1
3 major milestones in the next 18 months for our #Phase3 study in PKU. Learn more here: $SYBX #SYBX #biotechstocks #investmentideas #catalysts #raredisase
0
0
6
The #PKU Synpheny-3 Clinical Trial is now available in Gainesville, FL! Virtual, hybrid, and in-person options for participation are available. Scan the QR code to learn more and to speak to Synlogic's clinical trial case manager.
0
0
1
Among 2023's wins: our IP team's securing protection for the innovations behind SYNB1934 (a.k.a. labafenogene marselecobac). Read up on our accomplishments and upcoming milestones: #biotechinnovation $SYBX #SYBX #biotechstocks #investmentideas
0
0
1
The #PKU Synpheny-3 Clinical Trial is now available in Charleston, SC! Virtual, hybrid, and in-person options for participation are also available. Scan the QR code to learn more and to speak to Synlogic's clinical trial case manager.
0
0
3
Ramp up on SYBX and our upcoming milestones! Last week's webcast can be seen here: Thank you @SidotiResearch! #sidoti $SYBX #SYBX #biotechstocks #investmentideas #growthstocks #valuestocks
0
0
4
Curious about PKU, and why Phe lowering is so important in this rare metabolic disease? In this brief clip (2 mins), Dr. Hope Northrup, medical geneticist and expert in #inbornerrors, explains: #SYBX $SYBX #rarediseases #drugdevelopment
0
0
4
Learn about our ongoing, pivotal study in #PKU in this brief (~2 min) video: or visit #phenylketonuria #rarediseases #biotechstocks $SYBX
0
0
2
The #PKU Synpheny-3 Clinical Trial is now available in Aurora, CO! Virtual, hybrid, and in-person options for participation are available. Scan the QR code to learn more and to speak to Synlogic's clinical trial case manager. #CUAnschutz #CUMedicine @CUAnschutz @CUMedicine
0
0
2
Get the latest on Synlogic's important work in rare metabolic diseases, and exciting upcoming milestones for our Ph 3 program in PKU. Watch here: Thank you @SidotiResearch! #sidoti $SYBX #SYBX #biotechstocks #growthstocks #valuestocks
0
0
3
The #PKU Synpheny-3 Clinical Trial is now available in Palo Alto, CA! Virtual, hybrid, and in-person options for participation may be available. To learn more and to speak to our Synlogic clinical trial case manager, visit
0
0
3
Synpheny-3 clinical trial is open in the US! In this video, Synlogic team members answer FAQs we've received about the ongoing Synpheny-3 clinical trial. Learn more:
0
0
2
SynPheny-3 Clinical Trial is actively recruiting participants living with #PKU. We've made participation flexible with a fully virtual option, so you can participate from almost anywhere in the US!. Learn more and sign up today. #PKU #ClinicalTrial #SynPheny3
0
0
1
ICYMI! Learn from our team about Synlogic's late-stage programs in rare metabolic diseases, and exciting upcoming milestones for our Ph 3 program in PKU: Thank you @SidotiResearch! #sidoti $SYBX #SYBX #biotechstocks #growthstocks #valuestocks
0
0
2